Clinical Trials Browser

Phase 3 × Prostate Adenocarcinoma × Leuprolide × Clear all

NCT05050084 2026-04-08

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Phase 3 Active not recruiting

Prostate Adenocarcinoma